# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-25 | **更新时间**: 06:57 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- *当前暂无过去 24 小时内的相关重磅全球资讯。*

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[17:15]` **国家药监局药审中心关于发布《嵌合抗原受体T细胞治疗药品说明书临床相关信息撰写指导原则》的通告** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5UX3dYWlRsel9iTmp4aWFXZU9KNzk2YnU1Wkc0b3N5dGNEVnF3ZkNXd1k5clAyenVMMHowMVJuRS1sZFRfYXl6aGhrOUl6cjBWNDdadEMzVXd1Q0VSOEU2d1owSEtlUzhSbzZUTGdLSGhfM3c4Q3BNSEdkc2E0Zw?oc=5)
- `[17:08]` **全球首创！张江纽伦捷IND再突破，这个“一次性治愈”产业冲刺临床新赛道** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE9zdk1QNy1YWmxYajlpTHotb2IxTzMzTlVpYzlpTUVieGVFWE9NZ0g2anBRNEhhRGNUZXVnVjhCOHZaOFB0VWJMd0lkQ1V1bHBJSmRBTFo3VXY0SDhJTWIzb0Fva2VoQnNwVlB2b3dFUkxPLWtwdUtSUjZnOGlTUQ?oc=5)
- `[11:47]` **🔥In-vivo | 东方证券：自体CAR-T价格劣势格外突出 in vivo CAR-T是解决问题潜力方向 提供者 智通财经** [🔗阅读原文](https://news.google.com/rss/articles/CBMicEFVX3lxTFBnemotS1Y0M0FrSDgwaURZYXA1cDQ2YjZsSnl3S25XdmxZcWg5UGdwOUFKUjV0aW5vZGxEeHhfV1U5NTB0c1kwX3h0ZzVJcVVTTjAxYkduWU1lcDBmVGlkc0prcHpKNFk1ckF4YkVhNHg?oc=5)
- `[10:21]` **Statistics in Medicine：PRIDE方案破解罕见病临床招募难题，MTD识别精准度拉满-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTE9TM2VFNFZseXBOb2N6SVJoY2c0RFpUOXNkdGNQMGc2M1pEZjF3R2ZPbm5MdHNteloxNHpoRGJTZkVBc3RGOWZmTVRINjVEWlVyT1BudWhjemRaTVhFZkhucVRWSDdDMnNuQXgyMk1R?oc=5)
